These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 13062671)
1. [Contribution to the study of biological behaviors induced by antituberculosis vaccination with living and dead micro-organisms]. DEGLI ESPOSTI A Lotta Tuberc; 1953; 23(1-2):78-89. PubMed ID: 13062671 [No Abstract] [Full Text] [Related]
2. [Tuberculosis prevention, specific for childhood; antitubercular vaccination]. MALLARDI A Pediatria (Napoli); 1955; 63(6):1075-86. PubMed ID: 13310055 [No Abstract] [Full Text] [Related]
3. REGRESSION TECHNIQUES TO SOLVE UNEQUAL CHALLENGE POTENCY PROBLEMS IN ANTITUBERCULOSIS VACCINE ASSAYS. HOYT A; MOORE FJ; THOMPSON MA Am Rev Respir Dis; 1964 Jan; 89():111-5. PubMed ID: 14117678 [No Abstract] [Full Text] [Related]
4. [Biological factors induced by antituberculosis vaccinations with live (BCG) and dead (AIP) bacteria]. GALZERANO G; SCOZIA A Arch Tisiol Mal Appar Respir; 1953 May; 8(5):355-9. PubMed ID: 13093309 [No Abstract] [Full Text] [Related]
5. [INCREASE OF ASPECIFIC DEFENSE GIVEN BY ANTITUBERCULAR VACCINATION]. ZIRONI A Clin Pediatr (Bologna); 1964 Oct; 46():899-906. PubMed ID: 14264988 [No Abstract] [Full Text] [Related]
7. [BCG and infantile tuberculosis; experiences of an antituberculosis campaign in a Swedish province]. BRANDBERG O Ann Paediatr; 1955 Sep; 185(3):178-88. PubMed ID: 13259259 [No Abstract] [Full Text] [Related]
9. [Antituberculosis vaccination in the Preventive Medicine Service of the University of Strasbourg]. VAUCHER E; OUDET P Rev Tuberc; 1950; 14(12):1226-9. PubMed ID: 14845487 [No Abstract] [Full Text] [Related]
10. [Experimental tuberculosis in non-vaccinated dogs and in dogs vaccinated with living (BCG) and dead (AIP, VPS and VDS) bacilli]. SALVIOLI G; DEGLI ESPOSTI A; DINA MA Acta Tuberc Scand; 1953; 28(1-2):147-54. PubMed ID: 13079975 [No Abstract] [Full Text] [Related]
12. [Killed antituberculosis vaccine potentialized by diffusion factor in laboratory experiments]. SALVIOLI G Minerva Med; 1953 Mar; 44(22):697-706. PubMed ID: 13071909 [No Abstract] [Full Text] [Related]
13. [Fifty years of the history of antituberculosis killed-bacilli vaccination in humans]. DE TONI G Minerva Med; 1953 Jun; 44(45):1503-12. PubMed ID: 13072081 [No Abstract] [Full Text] [Related]
14. [Antituberculosis vaccination in humans: comparison of killed and live bacilli vaccines]. DE TONI G Minerva Med; 1953 Jun; 44(46):1531-40. PubMed ID: 13072086 [No Abstract] [Full Text] [Related]
15. [Childhood antituberculosis prophylaxis in preventive infirmaries and vaccination with c BCG]. FERREIRA C Rev Bras Tuberc Doencas Torac; 1947; 16(111):163-8. PubMed ID: 18897133 [No Abstract] [Full Text] [Related]
16. THE EFFECT OF ADJUVANTS ON A NONVIABLE ANTITUBERCULOSIS VACCINE AND ON LIVE BCG. HOYT A; THOMPSON MA; MOORE FJ; SMITH CR Am Rev Respir Dis; 1965 Apr; 91():565-74. PubMed ID: 14263935 [No Abstract] [Full Text] [Related]
17. [Data relative to methods of the antituberculosis campaign among childrn and adolescents in France]. GERBAUX J; MANDE R Pediatrie; 1962; 17():737-55. PubMed ID: 13947313 [No Abstract] [Full Text] [Related]
18. [THE REASON FOR OUR DISAPPOINTMENTS IN THE ANTITUBERCULOSIS CAMPAIGN]. VIDAL J Sem Hop; 1964 Dec; 40():2879-81. PubMed ID: 14256577 [No Abstract] [Full Text] [Related]
19. Importance of administration of vaccine in active prevention of tuberculosis with BCG and with dead bacteria; Sivori's enzyme reaction to guinea pig following intradermal and hypodermal administration of BCG and of whole Petragnani anatuberculin. ESPOSTI AD Clin Pediatr (Bologna); 1953 Jan; 35(1):56-61. PubMed ID: 13042981 [No Abstract] [Full Text] [Related]
20. [New aspects in antituberculosis BCG vaccination]. VILLAR SALINAS J Rev Sanid Hig Publica (Madr); 1954; 28(7-8):485-531. PubMed ID: 13225145 [No Abstract] [Full Text] [Related] [Next] [New Search]